Marimed (MRMD) Shares Outstanding (2011 - 2026)

Marimed (MRMD) has reported Shares Outstanding (Entity) for 16 consecutive years, with $401.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 2.34% year-over-year to $401.2 million in Q2 2026; TTM through Jun 2026 was $401.2 million, a 2.34% increase from a year earlier, with the FY2025 full-year figure at $396.9 million, up 4.05% from the prior year.
• Shares Outstanding (Entity) was $401.2 million for Q2 2026 at Marimed, up from $398.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $401.2 million in Q2 2026 and troughed at $335.6 million in Q1 2022.
• A 5-year average of $373.1 million and a median of $378.1 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) grew 10.79% in 2023 and advanced 1.36% in 2024, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $341.5 million in 2022, then climbed by 9.85% to $375.1 million in 2023, then climbed by 1.69% to $381.5 million in 2024, then climbed by 4.05% to $396.9 million in 2025, then increased by 1.07% to $401.2 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $401.2 million (Q2 2026), $398.9 million (Q1 2026), and $396.9 million (Q4 2025), per Business Quant data.